B cell receptor inhibition as a target for CLL therapy
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference74 articles.
1. https://www.lls.org/sites/default/files/file_assets/facts.pdf; http://seer.cancer.gov/statfacts/html/clyl.html.
2. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia;Tam;Blood,2008
3. B cell antigen receptor signaling: roles in cell development and disease;Gauld;Science,2002
4. Perspectives on the nature of BCR-mediated survival signals;Smith;Mol Cell,2004
5. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia;Buchner;Cancer Res,2009
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2;Leukemia;2020-08-21
2. Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape;Current Treatment Options in Oncology;2020-03
3. Exploring a Future for PI3K Inhibitors in Chronic Lymphocytic Leukemia;Current Hematologic Malignancy Reports;2019-06-15
4. Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia;Clinical Cancer Research;2019-04-02
5. Dose and drug changes in chronic lymphocytic leukemia cell response in�vitro: A comparison of standard therapy regimens with two novel cyclin‑dependent kinase inhibitors;Molecular Medicine Reports;2019-03-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3